Clinical Trials Logo

Clinical Trial Summary

The project aims at investigating if treatment with the Angiotensin Converting Enzyme inhibitor Coversyl (perindopril) for 3 months after surgery for chronic subdural hematoma will decrease the risc of recurrence.


Clinical Trial Description

Previous studies have indicated that treatment with ACE inhibitors can reduce the risk of recurrence of CSDH after surgical evacuation. This randomized clinical trial was designed to investigate this ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00915928
Study type Interventional
Source Odense University Hospital
Contact
Status Terminated
Phase N/A
Start date July 2009
Completion date June 2012

See also
  Status Clinical Trial Phase
Recruiting NCT04742920 - The Onyx™ Trial For The Embolization Of The Middle Meningeal Artery For Chronic Subdural Hematoma (OTEMACS) N/A
Recruiting NCT05327933 - Preventing Recurrences of Chronic Subdural Hematoma in Adult Patients by Middle Meningeal Artery Embolization N/A
Recruiting NCT05426889 - The Role of Meningeal Lymphatic Vessels in the Absorption of Chronic Subdural Hematoma and Its Injury Mechanism N/A
Completed NCT01930617 - Irrigation of Chronic Subdural Hematomas - is More Better? N/A
Recruiting NCT03582293 - Tranexamic Acid to Prevent OpeRation in Chronic Subdural Hematoma Phase 3
Completed NCT03755349 - Covers to Improve Esthetic Outcome After Surgery for Chronic Subdural Hematoma N/A
Terminated NCT02362321 - Role of Dexamethasone in the Conservative Treatment of Chronic Subdural Hematoma Phase 4
Recruiting NCT04573387 - Exhaustive Drainage Versus Fixed-time Drainage for Chronic Subdural Hematoma After One-burr Hole Craniostomy N/A
Withdrawn NCT03845322 - Curcumin/Turmeric as a Treatment for Patients With Subdural Hematomas Recurrence Early Phase 1